Lupin completes acquisition of portfolio of brands from Anglo-French Drugs & Industries

"India is critical in shaping Lupin's growth story going forward. This acquisition strengthens our position in the Indian market, where we have already established ourselves as a leading provider of quality pharmaceuticals and a trusted partner," Lupin Managing Director Nilesh Gupta noted.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/iFnhvXD
via IFTTT